Hauck Matthew J, Steele Eric A, Perry C Blake
Medical Eye Center, Medford, Oregon.
Casey Eye Institute, Oregon Health and Sciences University, Portland, Oregon.
Ophthalmic Plast Reconstr Surg. 2020 Mar/Apr;36(2):191-193. doi: 10.1097/IOP.0000000000001510.
To evaluate the ability of preoperative phenylephrine testing to predict postoperative upper eyelid tarsal platform show in patients undergoing Müller muscle-conjunctival resection (MMCR) ptosis repair without concurrent blepharoplasty.
A retrospective chart review was performed on 52 eyelids of patients who underwent MMCR without external skin incision. Photographs were reviewed to objectively and subjectively compare the results of phenylephrine testing to postoperative appearance. Only patients who underwent successful MMCR were included in the study. The authors defined successful MMCR as having a resulting marginal reflex distance within 1 mm of that predicted by phenylephrine testing. For objective analysis, the tarsal platform show was measured using computer software. For subjective analysis, 2 experienced examiners were asked to grade the correlation in appearance on a scale of 1-5 (1 being poor correlation and 5 being excellent correlation).
The mean tarsal platform show in the phenylephrine test photographs and the postoperative photographs was 3.8 and 3.63 mm, respectively (mean = 0.17; standard deviation = 0.71). The difference between the means was not statistically significant (p > 0.05). The mean difference in tarsal platform show between phenylephrine testing and postoperative was 0.17 mm (standard deviation = 0.71). The difference was not statistically significant (t[51] = 0.09; p > 0.05; 2 tailed). The mean subjective correlation score comparing phenylephrine testing photographs to postoperative photographs was 4.4 out of possible 5.
Phenylephrine testing exhibits good predictability with regard to eyelid appearance after successful MMCR without external skin incision and, therefore, may assist the surgeon when trying to decide if blepharoplasty or eyelid crease formation is necessary at the time of MMCR.
评估术前使用去氧肾上腺素测试预测 Müller 肌-结膜切除术(MMCR)修复上睑下垂患者术后上睑睑板平台显露情况的能力,这些患者未同时进行眼睑成形术。
对 52 只未行外皮肤切口的 MMCR 患者眼睑进行回顾性病历审查。回顾照片以客观和主观地比较去氧肾上腺素测试结果与术后外观。仅纳入 MMCR 手术成功的患者。作者将成功的 MMCR 定义为最终的边缘反射距离与去氧肾上腺素测试预测值相差在 1mm 以内。对于客观分析,使用计算机软件测量睑板平台显露情况。对于主观分析,邀请 2 名经验丰富的检查者以 1-5 分的量表对外观相关性进行评分(1 分表示相关性差,5 分表示相关性极佳)。
去氧肾上腺素测试照片和术后照片中的平均睑板平台显露分别为 3.8mm 和 3.63mm(均值 = 0.17;标准差 = 0.71)。均值之间的差异无统计学意义(p > 0.05)。去氧肾上腺素测试与术后睑板平台显露的平均差异为 0.17mm(标准差 = 0.71)。差异无统计学意义(t[51] = 0.09;p > 0.05;双侧)。将去氧肾上腺素测试照片与术后照片进行比较的主观相关性平均评分为 4.4 分(满分 5 分)。
在未行外皮肤切口的成功 MMCR 术后,去氧肾上腺素测试对眼睑外观具有良好的预测性,因此,在 MMCR 时外科医生决定是否需要进行眼睑成形术或形成眼睑皱襞时可能会有所帮助。